Generated by GPT-5-mini| Data Collective | |
|---|---|
| Name | Data Collective |
| Type | Venture capital firm |
| Founded | 2011 |
| Founders | Matt Ocko; Zachary Bogue |
| Headquarters | San Francisco, California |
| Industry | Venture capital; deep tech; biotechnology; artificial intelligence |
Data Collective
Data Collective is a venture capital firm focused on early-stage and growth-stage companies in deep technology sectors including artificial intelligence, biotechnology, robotics, spaceflight, and quantum computing. Founded in 2011 in San Francisco, California, the firm has participated in rounds alongside firms such as Sequoia Capital, Andreessen Horowitz, Kleiner Perkins, General Catalyst, and Founders Fund. Its portfolio includes companies that have operated in ecosystems around Silicon Valley, Boston, Massachusetts, Seattle, Washington, San Diego, California, and international hubs such as Tel Aviv, Cambridge, England, and Beijing.
The firm was established by entrepreneurs and investors who had backgrounds at institutions including Stanford University, Massachusetts Institute of Technology, University of California, Berkeley, and companies such as Google, Palantir Technologies, Intel, Amazon (company), and NASA. Early activity placed investments into startups emerging from programs like Y Combinator, Plug and Play Tech Center, and university spinouts from Harvard University and Caltech. Over time, the firm expanded its involvement in corporate venture initiatives alongside strategic partners such as Lockheed Martin, Boeing, Thermo Fisher Scientific, and Pfizer, reflecting cross-sector links to DARPA, NIH, NSF, and European Space Agency research funding networks.
Data Collective’s strategy emphasizes deep-science founders with backgrounds from research organizations such as Lawrence Berkeley National Laboratory, Argonne National Laboratory, Los Alamos National Laboratory, and CERN. The firm targets sectors including machine learning, synthetic biology, nanotechnology, materials science, autonomous vehicles, and satellite communications. It typically leads or co-leads Series A and Seed rounds alongside institutional partners like Benchmark (venture capital) and Greylock Partners, and collaborates with corporate venture arms including GV (company), Intel Capital, and Salesforce Ventures. Investment decisions often reference technical milestones achieved at incubators and accelerators such as IndieBio, Y Combinator, and Rocket Lab collaborations.
The firm’s portfolio has spanned companies that achieved outcomes including public listings on exchanges like the Nasdaq and New York Stock Exchange, acquisitions by conglomerates such as Alphabet Inc., Microsoft, Amazon (company), and Thermo Fisher Scientific, and strategic mergers with firms including Illumina, ARM Holdings, and NVIDIA. Specific portfolio companies have included leaders in synthetic biology and gene editing that collaborated with Regeneron Pharmaceuticals, Novartis, and Roche. Other investments targeted startups in spaceflight and satellite constellations that contracted with SpaceX, Blue Origin, Lockheed Martin, and Northrop Grumman. Exits involved secondary transactions with crossover funds like Tiger Global Management and SoftBank Vision Fund as well as initial public offerings supported by banks such as Goldman Sachs, Morgan Stanley, and JPMorgan Chase.
The leadership team has included partners with prior roles at Sequoia Capital, Bessemer Venture Partners, Silver Lake Partners, and technology companies including Facebook, Palantir Technologies, Dropbox, and Stripe. Advisory board members have come from research institutions such as MIT, Stanford University, UC Berkeley, and industry labs like IBM Research and Microsoft Research. The firm’s operating model integrates venture partners, entrepreneurs-in-residence drawn from startups like Uber Technologies, Airbnb, and Pinterest, and technical advisors who have held appointments at Harvard Medical School, Columbia University, and Johns Hopkins University.
Funds managed by the firm have reported capital allocations across multiple vintage years, attracting limited partners including university endowments such as Harvard Management Company, Yale University, and Stanford Management Company, sovereign wealth funds like Temasek Holdings and Abu Dhabi Investment Authority, and family offices tied to tech founders from Apple Inc. and Oracle Corporation. Portfolio outcomes have contributed to advances in sectors linked to climate change mitigation technologies, commercialization pathways for CRISPR-related therapeutics, and deployment of low Earth orbit communications infrastructure. Performance metrics cited in industry analyses compared returns against benchmarks maintained by Cambridge Associates, Preqin, and PitchBook.
Category:Venture capital firms